Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alkylating Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01132586
What this trial is testing

Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+10 more
National Cancer Institute (NCI) 61
Testing effectiveness (Phase 2)Ended earlyNCT02627573
What this trial is testing

Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

Who this might be right for
Leukemia, Chronic MyeloidMyelodysplastic SyndromesLeukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
St. Petersburg State Pavlov Medical University 32
Not applicableActive Not RecruitingNCT02467231
What this trial is testing

Ovarian Reserve After Cancer: Longitudinal Effects

Who this might be right for
Effects of ChemotherapyPremature Ovarian Failure
University of Pennsylvania 196
Testing effectiveness (Phase 2)Ended earlyNCT01397149
What this trial is testing

Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG)

Who this might be right for
Chronic Lymphocytic LeukemiaThrombocytopenia
University of Ulm 4
Large-scale testing (Phase 3)UnknownNCT02856048
What this trial is testing

Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer

Who this might be right for
CancerToxicity Due to ChemotherapySarcoma+3 more
Assistance Publique - Hôpitaux de Paris 11
Early research (Phase 1)Study completedNCT01834248
What this trial is testing

DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAlkylating Agent-Related Acute Myeloid LeukemiaChronic Myelomonocytic Leukemia+2 more
Roswell Park Cancer Institute 9
Testing effectiveness (Phase 2)Study completedNCT01282424
What this trial is testing

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

Who this might be right for
Follicular LymphomaSmall Lymphocytic LymphomaLymphoplasmacytic Lymphoma+1 more
Gilead Sciences 125
Testing effectiveness (Phase 2)Study completedNCT00002680
What this trial is testing

Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Yale University 40
Testing effectiveness (Phase 2)Study completedNCT00050427
What this trial is testing

ET-743 (Trabectedin) in Patients With Advanced Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasmsNeoplasms by Site+2 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT01864109
What this trial is testing

Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma

Who this might be right for
Newly Diagnosed Ewing Sarcoma
Memorial Sloan Kettering Cancer Center 83
Early research (Phase 1)Study completedNCT01254578
What this trial is testing

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11+39 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT01870596
What this trial is testing

Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic Leukemia+12 more
National Cancer Institute (NCI) 32
Early research (Phase 1)Study completedNCT00970580
What this trial is testing

BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Biogen 18
Testing effectiveness (Phase 2)Study completedNCT00003635
What this trial is testing

506U78 in Treating Patients With Chronic Lymphocytic Leukemia That Has Not Responded to Fludarabine or Alkylating Agents

Who this might be right for
Leukemia
GlaxoSmithKline
Very early researchActive Not RecruitingNCT01189643
What this trial is testing

Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor

Who this might be right for
SarcomaDesmoplastic Small Round Cell Tumor (DSRCT)
Memorial Sloan Kettering Cancer Center 15
Large-scale testing (Phase 3)Study completedNCT01303887
What this trial is testing

A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients

Who this might be right for
Follicular Lymphoma
University of Liverpool 680
Testing effectiveness (Phase 2)Study completedNCT02126553
What this trial is testing

Lenalidomide in Treating Patients With High Risk Acute Myeloid Leukemia in Remission

Who this might be right for
Alkylating Agent-Related Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Looking for participantsNCT05512481
What this trial is testing

Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma

Who this might be right for
MelanomaAcral MelanomaTemozolomide+4 more
Peking University Cancer Hospital & Institute 60
Large-scale testing (Phase 3)Ended earlyNCT00448266
What this trial is testing

Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 12
Early research (Phase 1)Ended earlyNCT01542047
What this trial is testing

A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies

Who this might be right for
Cancer, Metastatic
New Mexico Cancer Research Alliance 3
Next Page